| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016573 | HBV | ENSG00000102468.11 | protein_coding | HTR2A | No | No | 3356 | P28223 |
| TVIS44041305 | HTLV-1 | ENSG00000102468.11 | protein_coding | HTR2A | No | No | 3356 | P28223 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HTR2A |
|---|---|
| DrugBank ID | DB01488 |
| Drug Name | Dimethyltryptamine |
| Target ID | BE0000451 |
| UniProt ID | P28223 |
| Regulation Type | |
| PubMed IDs | 2540505; 19278957 |
| Citations | Pierce PA, Peroutka SJ: Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex. Psychopharmacology (Berl). 1989;97(1):118-22.@@Su TP, Hayashi T, Vaupel DB: When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal. 2009 Mar 10;2(61):pe12. doi: 10.1126/scisignal.261pe12. |
| Groups | Experimental; Illicit |
| Direct Classification | Tryptamines and derivatives |
| SMILES | CN(C)CCC1=CNC2=CC=CC=C12 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL12420 |
